Testosterone Inactivating Pharmaceuticals (TIP)
BY MARK SCHOLZ, MD Hormones play a large role in cancer growth. They are also integral to treatment. Testosterone is a key player. It originates mostly in the testicles and, …
Making an Informed Decision about Prostate Cancer
BY MARK SCHOLZ, MD What Is the Best Therapy for Me? This is one of the greatest questions for men with prostate cancer. How do you arrive at a reliable …
Breakthroughs for Hormone-Resistant Prostate Cancer
BY MARK SCHOLZ, MD The value of a new medical treatment is gauged by the seriousness of the problem it overcomes. Hormone-resistant prostate cancer—that is, prostate cancer that has become …
10 Myths of Prostate Cancer
BY MARK SCHOLZ, MD I have cared for prostate cancer patients for more than 20 years. Patients come to me with all kinds of wrong notions. Here are 10 of …
Selecting the Best Therapy for Newly-Diagnosed Prostate Cancer
BY MARK SCHOLZ, MD Due to the absence of well-designed comparative studies, treatment selection for prostate cancer has been highly controversial. However, in October 2016, two landmark articles published in the New England …
Preventing Hormone Therapy Side Effects
BY MARK SCHOLZ, MD A number of interventions are available that can substantially reduce adverse side effects from testosterone inactivating pharmaceuticals (TIP). Side effects vary from patient to patient and are influenced by the …
Avodart & Proscar for Treating Prostate Cancer
BY MARK SCHOLZ, MD Avodart and Proscar are FDA-approved for treating urinary side effects from prostate enlargement. The generic name for Avodart is dutasteride; the generic name for Proscar is finasteride. These medications, …